LENSAR, Inc. (LNSR) Stock

Healthcare · Medical Devices · Member of Other US Stocks

LENSAR, Inc. (LNSR) closed at USD 6.11 on 2026-10-14, a change of -48.5 % over the past year, with a market capitalization of USD 74.08M.

LENSAR, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

LENSAR, Inc. key figures

Previous close

USD 6.11 (2026-10-14)

1-year change

-48.5 %

Market cap

USD 74.08M

Enterprise value

USD 76.68M

P/E ratio (trailing)

35.47

P/E ratio (forward)

-11.82

EPS (trailing)

0.17

EPS (forward)

-0.51

PEG ratio

n/a

Price to book

4.97

Revenue growth

18.4 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

4.90

Employees

150

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About LENSAR, Inc.

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for LENSAR, Inc. and compare it with other stocks.